세계의 바이오 분석 검사 서비스 시장 : 시장 규모, 점유율, 동향 분석 - 분자별, 검사별, 워크플로우별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Bioanalytical Testing Services Market Growth & Trends:

The global bioanalytical testing services market size is anticipated to reach USD 8.02 billion by 2030 and is projected to grow at a CAGR of 9.21% from 2025 to 2030, according to a new report by Grand View Research, Inc. An increasing rate of outsourcing R&D activities by several biopharmaceutical companies to streamline their core competencies is one of the major factors supporting the market growth. In addition, the outbreak of COVID-19 has further boosted demand for pharma-analytical testing services as the rapid surge in SARS-CoV-2 infection cases has significantly augmented the production of a larger batch of COVID-19 vaccines across the globe.

Furthermore, the growing demand for pharmaceutical products across the globe has resulted in a surge of pipeline drugs that require bioanalytical testing for development, thus augmenting the market growth. In addition, the market is expected to witness considerable growth over the forecast period owing to an increasing number of contract manufacturing companies expanding their development capacities across the globe. For instance, in September 2023, Cerba HealthCare announced the acquisition of CIRION BioPharma Research, a Canadian contract research laboratory, to expand its bioanalytical capabilities and reduce the time required for implementing intricate clinical trials.

Increasing awareness about product quality, environmental issues, and the safety of consumers are driving companies to outsource tests as a means to ensure that their products comply with the aforementioned aspects. This helps them build brand image and protects as well as enhances reputation. The U.S. FDA has conducted workshops to increase awareness regarding bioanalytical testing and related regulations.

Key operating companies are undertaking various strategic initiatives to strengthen their market presence. For instance, in August 2023, Pace Analytical Services announced the acquisition of Alpha Analytical, adding new capabilities such as advanced hydrocarbon analytical support along with expanded sediment & tissue testing. Moreover, in April 2022, Charles River Laboratories acquired Explora BioLabs, a prominent player in contract research services, for USD 295 million in cash. This has broadened the company's operating capabilities in the market.

Bioanalytical Testing Services Market Report Highlights:

• Small molecule segment accounted for the largest revenue share of over 55.3% in 2024. The high demand for generic drug development boosts the segment growth
• Large molecule segment is anticipated to witness fastest CAGR during the forecast period. This is attributed to the increased investment and focus on the development of biopharmaceuticals
• The bioequivalence segment is estimated to witness the fastest CAGR during the forecast period. This is attributed to the growing production and consumption of generics & biosimilars
• The sample preparation segment held a significant market share in 2024 and is estimated to expand further at the fastest CAGR from 2025 to 2030
• North America was the largest regional market in 2024 due to the strong presence of several pharmaceutical players in the U.S.
• On the other hand, the market in Asia Pacific is projected to register the fastest CAGR from 2025 to 2030 owing to increasing pharmaceutical & biotechnology activities, rising healthcare expenditure

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Purchased Database
  • 1.3.3. GVR's Internal Database
  • 1.3.4. Secondary Sources
  • 1.3.5. Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Information Analysis
  • 1.4.2. Market Formulation & Data Visualization
  • 1.4.3. Data Validation & Publishing
• 1.5. Model Details
  • 1.5.1. Commodity Flow Analysis (Model 1)
  • 1.5.2. Top Down Market Estimation (Model 2)
  • 1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
  • 1.5.4. Multivariate Analysis (Model 4)
• 1.6. List of Secondary Sources
• 1.7. List of Abbreviations
• 1.8. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
  • 3.3.2. Market Restraint Analysis
• 3.4. Investments & Funding Perspective
• 3.5. Clinical Trials Volume Analysis, (2024)
  • 3.5.1. Total Number of Clinical Trials, by Region (2024)
  • 3.5.2. Total Number of Clinical Trials, by Phase (2024)
  • 3.5.3. Total Number of Clinical Trials, by Study Design (2024)
  • 3.5.4. Total Number of Clinical Trials, by Key Therapeutic Area (2024)
• 3.6. Technology Landscape
• 3.7. Pricing Model Analysis
• 3.8. Industry Analysis Tools
  • 3.8.1. Porter's Five Forces Analysis
  • 3.8.2. PESTEL Analysis
  • 3.8.3. COVID-19 Impact Analysis

Chapter 4. Bioanalytical Testing Services Market: Molecule Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Bioanalytical Testing Services Market; Molecule Movement Analysis
• 4.3. Bioanalytical Testing Services Size & Trend Analysis, by Molecule, 2018 to 2030 (USD Million)
• 4.4. Small Molecule
  • 4.4.1. Small molecule market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Large Molecule
  • 4.5.1. Large molecule market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.2. LC-MS studies
    • 4.5.2.1. LC-MS studies market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Immunoassays
    • 4.5.3.1. Immunoassays market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3.2. Pharmacokinetics (PK)
      • 4.5.3.2.1. Pharmacokinetics (PK) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3.3. ADA assay
      • 4.5.3.3.1. ADA assay market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3.4. Other
      • 4.5.3.4.1. Other large molecule tests market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.4. Other large molecule tests
    • 4.5.4.1. Other large molecule tests market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Bioanalytical Testing Services Market: Test Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Bioanalytical Testing Services Market; Test Movement Analysis
• 5.3. Bioanalytical Testing Services Size & Trend Analysis, by Test, 2018 to 2030 (USD Million)
• 5.4. ADME
  • 5.4.1. ADME market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Pharmacokinetics (PK)
  • 5.5.1. Pharmacokinetics (PK) market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Pharmacodynamics (PD)
  • 5.6.1. Pharmacodynamics (PD) market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Bioavailability
  • 5.7.1. Bioavailability market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Bioequivalence
  • 5.8.1. Bioequivalence market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. Biomarker testing
  • 5.9.1. Biomarker testing market estimates and forecasts 2018 to 2030 (USD Million)
• 5.10. Cell-based assay
  • 5.10.1. Cell-based assay market estimates and forecasts 2018 to 2030 (USD Million)
• 5.11. Virology testing
  • 5.11.1. Virology testing market estimates and forecasts 2018 to 2030 (USD Million)
• 5.12. Other tests
  • 5.12.1. Other tests market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Bioanalytical Testing Services Market: Workflow Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Bioanalytical Testing Services Market; Workflow Movement Analysis
• 6.3. Bioanalytical Testing Services Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
• 6.4. Sample Collection and Preparation
  • 6.4.1. Sample collection and preparation market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Sample collection, handling and storage
    • 6.4.2.1. Sample collection, handling and storage market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Protein precipitation
    • 6.4.3.1. Protein precipitation market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Liquid-Liquid extraction
    • 6.4.4.1. Liquid-Liquid extraction market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.5. Solid Phase extraction
    • 6.4.5.1. Solid phase extraction market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.6. Others
    • 6.4.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Method Development and Validation
  • 6.5.1. Method development and validation market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Sample analysis
  • 6.6.1. Sample analysis market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Hyphenated technique
    • 6.6.2.1. Hyphenated technique market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.3. Chromatographic technique
    • 6.6.3.1. Chromatographic technique market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.4. Electrophoresis
    • 6.6.4.1. Electrophoresis market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.5. Ligand binding assay
    • 6.6.5.1. Ligand binding assay market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.6. Mass spectrometry
    • 6.6.6.1. Mass spectrometry market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.7. Spectroscopic techniques
    • 6.6.7.1. Spectroscopic techniques market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7.2. Nuclear Magnetic Resonance (NMR)
      • 6.6.7.2.1. Nuclear Magnetic Resonance (NMR) market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7.3. Others
      • 6.6.7.3.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.8. Genomic and Molecular Techniques
    • 6.6.8.1. Genomic and molecular techniques market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8.2. Polymerase Chain Reaction (PCR)
      • 6.6.8.2.1. Polymerase Chain Reaction (PCR) market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8.3. Next-Generation Sequencing (NGS)
      • 6.6.8.3.1. Next-Generation Sequencing (NGS) market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8.4. Others
      • 6.6.8.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Other processes
  • 6.7.1. Other processes market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Bioanalytical Testing Services Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Bioanalytical Testing Services Market; End Use Movement Analysis
• 7.3. Bioanalytical Testing Services Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Pharma & BioPharma Companies
  • 7.4.1. Pharma & biopharma companies market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. CDMO
  • 7.5.1. CDMO market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. CRO
  • 7.6.1. CRO market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Regional Business Analysis

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
• 8.3. North America
  • 8.3.1. North America bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Competitive scenario
    • 8.3.2.3. Regulatory framework
    • 8.3.2.4. U.S. bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Competitive scenario
    • 8.3.3.3. Regulatory framework
    • 8.3.3.4. Canada bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key country dynamics
    • 8.3.4.2. Competitive scenario
    • 8.3.4.3. Regulatory framework
    • 8.3.4.4. Mexico bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. Germany bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. UK
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. UK bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Competitive scenario
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. France bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Competitive scenario
    • 8.4.5.3. Regulatory framework
    • 8.4.5.4. Italy bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Competitive scenario
    • 8.4.6.3. Regulatory framework
    • 8.4.6.4. Spain bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.7. Netherlands
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Competitive scenario
    • 8.4.7.3. Regulatory framework
    • 8.4.7.4. Netherlands bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.8. Switzerland
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Competitive scenario
    • 8.4.8.3. Regulatory framework
    • 8.4.8.4. Switzerland bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.9. Denmark
    • 8.4.9.1. Key country dynamics
    • 8.4.9.2. Competitive scenario
    • 8.4.9.3. Regulatory framework
    • 8.4.9.4. Denmark bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.10. Sweden
    • 8.4.10.1. Key country dynamics
    • 8.4.10.2. Competitive scenario
    • 8.4.10.3. Regulatory framework
    • 8.4.10.4. Sweden bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.11. Norway
    • 8.4.11.1. Key country dynamics
    • 8.4.11.2. Competitive scenario
    • 8.4.11.3. Regulatory framework
    • 8.4.11.4. Norway bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Japan bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. China bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. India bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. South Korea bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Australia bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Competitive scenario
    • 8.5.7.3. Regulatory framework
    • 8.5.7.4. Thailand bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Indonesia
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Competitive scenario
    • 8.5.8.3. Regulatory framework
    • 8.5.8.4. Indonesia bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Malaysia
    • 8.5.9.1. Key country dynamics
    • 8.5.9.2. Competitive scenario
    • 8.5.9.3. Regulatory framework
    • 8.5.9.4. Malaysia bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.10. Singapore
    • 8.5.10.1. Key country dynamics
    • 8.5.10.2. Competitive scenario
    • 8.5.10.3. Regulatory framework
    • 8.5.10.4. Singapore bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.11. Taiwan
    • 8.5.11.1. Key country dynamics
    • 8.5.11.2. Competitive scenario
    • 8.5.11.3. Regulatory framework
    • 8.5.11.4. Taiwan bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Brazil bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. Argentina bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. Colombia
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Competitive scenario
    • 8.6.4.3. Regulatory framework
    • 8.6.4.4. Colombia bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. South Africa bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Saudi Arabia bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. UAE bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Competitive scenario
    • 8.7.5.3. Regulatory framework
    • 8.7.5.4. Kuwait bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Company Market Position Analysis, 2024
• 9.3. Company Profiles
  • 9.3.1. Thermo Fisher Scientific Inc
    • 9.3.1.1. Company overview
    • 9.3.1.2. Financial performance
    • 9.3.1.3. Service benchmarking
    • 9.3.1.4. Strategic initiatives
  • 9.3.2. ICON Plc
    • 9.3.2.1. Company overview
    • 9.3.2.2. Financial performance
    • 9.3.2.3. Service benchmarking
    • 9.3.2.4. Strategic initiatives
  • 9.3.3. Charles River Laboratories International
    • 9.3.3.1. Company overview
    • 9.3.3.2. Financial performance
    • 9.3.3.3. Service benchmarking
    • 9.3.3.4. Strategic initiatives
  • 9.3.4. IQVIA Inc.
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Service benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Syneos Health
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Service benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. SGS SA
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Service benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Labcorp
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Service benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Intertek Group Plc
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Service benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Pace Analytical Services LLC
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Service benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Wuxi AppTec
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Service benchmarking
    • 9.3.10.4. Strategic initiatives